Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/15/2025

Treatment for Gonorrhea Arthritis (Disseminated Gonococcal Infection)

Initial Treatment

  • The American College of Physicians recommends initiating treatment with ceftriaxone 1 g IV or IM every 24 hours PLUS azithromycin 1 g orally as a single dose, continuing parenteral therapy until clinical improvement, then transitioning to oral cefixime 400 mg twice daily to complete 7 days of total therapy, with a strength of evidence based on clinical guidelines 1, 2
  • The Centers for Disease Control and Prevention suggests adding azithromycin 1 g orally as a single dose on day 1 to address potential chlamydial coinfection and provide dual antimicrobial coverage to combat resistance, with a strength of evidence based on clinical trials 1, 2

Transition to Oral Therapy

  • The MMWR Recommendations and Reports recommend switching to cefixime 400 mg orally twice daily to complete a total of 7 days of antimicrobial therapy, with a strength of evidence based on clinical guidelines 3
  • The total duration of therapy should be 7 days for uncomplicated gonococcal arthritis, or 10-14 days if meningitis is documented, with a strength of evidence based on clinical guidelines 3

Alternative Regimens

  • For patients with severe cephalosporin allergy, the American College of Physicians recommends using azithromycin 2 g orally as a single dose with mandatory test-of-cure at 1 week, though this has lower efficacy and high gastrointestinal side effects, with a strength of evidence based on clinical trials 1, 2
  • Consider gentamicin 240 mg IM single dose PLUS azithromycin 2 g orally as an alternative, though gentamicin has poor efficacy for pharyngeal infections, with a strength of evidence based on clinical trials 2

Partner Management and Follow-Up

  • The Centers for Disease Control and Prevention recommends evaluating and treating all sexual partners from the preceding 60 days with the same dual therapy regimen, with a strength of evidence based on clinical guidelines 1, 2
  • Instruct patients to avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic, with a strength of evidence based on clinical guidelines 1
  • Test for HIV and syphilis at the time of gonorrhea diagnosis, as gonorrhea facilitates HIV transmission, with a strength of evidence based on clinical trials 2

Special Populations

  • For pregnant women, the American College of Obstetricians and Gynecologists recommends using ceftriaxone 1 g IV/IM daily plus azithromycin 1 g orally, with a strength of evidence based on clinical guidelines 2
  • For neonates with disseminated gonococcal infection, the MMWR Recommendations and Reports recommend using ceftriaxone 25-50 mg/kg/day IV or IM for 7 days, with a strength of evidence based on clinical guidelines 3

Treatment Failure Management

  • If symptoms persist after 48-72 hours of appropriate therapy, obtain culture with antimicrobial susceptibility testing immediately, with a strength of evidence based on clinical guidelines 2
  • Report suspected treatment failure to local public health officials within 24 hours, with a strength of evidence based on clinical guidelines 2

REFERENCES

1

Treatment for Possible Gonorrhea Exposure [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Gonorrhea Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025